4.6 Article

Human Herpesvirus-6A/B Binds to Spermatozoa Acrosome and Is the Most Prevalent Herpesvirus in Semen from Sperm Donors

期刊

PLOS ONE
卷 7, 期 11, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0048810

关键词

-

资金

  1. Faculty of Health, Aarhus University
  2. Lundbeck Foundation
  3. Sanofi Pasteur MSD ApS

向作者/读者索取更多资源

An analysis of all known human herpesviruses has not previously been reported on sperm from normal donors. Using an array-based detection method, we determined the cross-sectional frequency of human herpesviruses in semen from 198 Danish sperm donors. Fifty-five of the donors had at least one ejaculate that was positive for one or more human herpesvirus. Of these 27.3% (n = 15) had a double herpesvirus infection. If corrected for the presence of multiple ejaculates from some donors, the adjusted frequency of herpesviruses in semen was 27.2% with HSV-1 in 0.4%; HSV-2 in 0.1%; EBV in 6.3%; HCMV in 2.7%; HHV-6A/B in 13.5%; HHV-7 in 4.2%, whereas none of the samples had detectable VZV or HHV-8. Subsequently, we examined longitudinally data on ejaculates from 11 herpesvirus-positive donors. Serial analyses revealed that a donor who tested positive for herpesvirus at one time point did not necessarily remain positive over time. For the most frequently found herpesvirus, HHV-6A/B, we examined its association with sperm. For HHV-6A/B PCR-positive semen samples, HHV-6A/B could be detected on the sperm by flow cytometry. Conversely, PCR-negative semen samples were negative by flow cytometry. HHV-6B was shown to associate with sperm within minutes in a concentration dependent manner. Confocal microscopy demonstrated that HHV-6B associated with the sperm head, but only to sperm with an intact acrosome. Taken together, our data suggest that HHV-6A/B could be transported to the uterus via binding to the sperm acrosome. Moreover, we find a 10 times higher frequency of HHV-7 in semen from healthy individuals than previously detected. Further research is required to determine the potential risk of using herpesvirus-positive donor semen. Longitudinally analyses of ejaculate series indicate that implementation of quarantine for a donor shown to shed a herpesvirus is not a tenable solution.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Infectious Diseases

Concordant testing results between various human papillomavirus assays in primary cervical cancer screening: systematic review

L. de Thurah, J. Bonde, J. U. H. Lam, M. Rebolj

CLINICAL MICROBIOLOGY AND INFECTION (2018)

Article Virology

The Valgent4 protocol: Robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath medium

Jesper Bonde, Ditte Moller Ejegod, Kate Cuschieri, Joakim Dillner, Danielle A. M. Heideman, Wim Quint, Miguel Angel Pavon Ribas, Elizaveta Padalko, Irene Kraus Christiansen, Lan Xu, Marc Arbyn

JOURNAL OF CLINICAL VIROLOGY (2018)

Article Oncology

Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort

Jesper Bonde, Fabio Bottari, Valentin Parvu, Helle Pedersen, Karen Yanson, Anna D. Iacobone, Salma Kodsi, Fabio Landoni, Laurence Vaughan, Ditte M. Ejegod, Maria T. Sandri

INTERNATIONAL JOURNAL OF CANCER (2019)

Article Oncology

FAM19A4/miR124-2 methylation in invasive cervical cancer: A retrospective cross-sectional worldwide study

Frederique J. Vink, Chris J. L. M. Meijer, Gary M. Clifford, Mario Poljak, Anja Ostrbenk, Karl Ulrich Petry, Beate Rothe, Jesper Bonde, Helle Pedersen, Silvia de Sanjose, Montserrat Torres, Marta del Pino, Wim G. Quint, Kate Cuschieri, Elia Alcaniz Boada, Nienke E. van Trommel, Birgit Lissenberg-Witte, Arno N. Floore, Albertus T. Hesselink, Renske D. M. Steenbergen, Maaike C. G. Bleeker, Danielle A. M. Heideman

INTERNATIONAL JOURNAL OF CANCER (2020)

Article Virology

Clinical performance of the HPV-Risk assay on cervical samples in SurePath medium using the VALGENT-4 panel

D. A. M. Heideman, L. Xu, A. T. Hesselink, S. Doorn, D. M. Ejegod, H. Pedersen, W. G. Quint, J. Bonde, M. Arbyn

JOURNAL OF CLINICAL VIROLOGY (2019)

Article Virology

Clinical validation of the Cobas 4800 HPV assay using cervical samples in SurePath medium under the VALGENT4 framework

Ditte Moller Ejegod, Mona Hansen, Irene Kraus Christiansen, Helle Pedersen, Wim Quint, Lan Xu, Marc Arbyn, Jesper Bonde

JOURNAL OF CLINICAL VIROLOGY (2020)

Article Oncology

Methylation markersFAM19A4andmiR124-2as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study

Jesper Bonde, Arno Floore, Ditte Ejegod, Frederique J. Vink, Albertus Hesselink, Peter M. van de Ven, Anja Ostrbenk Valencak, Helle Pedersen, Saskia Doorn, Wim G. Quint, Karl Ulrich Petry, Mario Poljak, Grazyna Stanczuk, Kate Cuschieri, Silvia de Sanjose, Maaike Bleeker, Johannes Berkhof, Chris J. L. M. Meijer, Danielle A. M. Heideman

Summary: The FAM19A4/miR124-2 methylation test shows a high sensitivity of 95% and specificity of 78.3% as a molecular triage test for HPV-positive cervical cancer screening. It can be considered as an effective alternative/supplement to cytology for cervical cancer screening.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Oncology

Classification of high-grade cervical intraepithelial neoplasia by p16ink4a, Ki-67, HPV E4 and FAM19A4/miR124-2 methylation status demonstrates considerable heterogeneity with potential consequences for management

Frederique J. Vink, Stefanie Dick, Danielle A. M. Heideman, Lise M. A. De Strooper, Renske D. M. Steenbergen, Birgit I. Lissenberg-Witte, Arno Floore, Jesper H. Bonde, Anja Ostrbenk Valencak, Mario Poljak, Karl U. Petry, Peter Hillemanns, Nienke E. van Trommel, Johannes Berkhof, Maaike C. G. Bleeker, Chris J. L. M. Meijer

Summary: This study evaluates the immunohistochemical expression of p16(ink4a) and Ki-67, known as the immunoscore (IS), in relation to HPV E4 expression and FAM19A4/miR124-2 methylation in high-grade CIN lesions. The findings suggest that these biomarker profiles may help clinicians in decision-making regarding immediate treatment or observation to avoid unnecessary overtreatment of high-grade CIN lesions.

INTERNATIONAL JOURNAL OF CANCER (2021)

Article Immunology

FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years

Frederique J. Vink, Chris J. L. M. Meijer, Albertus T. Hesselink, Arno N. Floore, Birgit Lissenberg-Witte, Jesper H. Bonde, Helle Pedersen, Kate Cuschieri, Ramya Bhatia, Mario Poljak, Anja Ostrbenk Valencak, Peter Hillemanns, Wim G. Quint, Marta del Pino, Gemma G. Kenter, Renske D. M. Steenbergen, Danielle A. M. Heideman, Maaike C. G. Bleeker

Summary: The FAM19A4/miR124-2 methylation test can detect nonproductive, transforming CIN2/3 lesions with high specificity in HPV-positive women under 30 years old, providing valuable information for treatment decisions.

CLINICAL INFECTIOUS DISEASES (2023)

Article Public, Environmental & Occupational Health

Operational experiences from the general implementation of HPV self-sampling to Danish screening non-attenders

Ditte Moller Ejegod, Helle Pedersen, Birgitte Tonnes Pedersen, Reza Serizawa, Jesper Bonde

Summary: The Danish cervical cancer screening program is a free cancer prevention program targeting women aged 23-64. Despite a declining attendance rate, nearly half of all new cervical cancer cases are found in non-attenders. To increase attendance, the Capital Region of Denmark introduced HPV self-sampling as an alternative option, resulting in a 27% participation rate. Overall, 31% of the invited women were screened.

PREVENTIVE MEDICINE (2022)

Letter Infectious Diseases

Can REALQUALITY RQ-HPV screen be considered as a clinically validated HPV test for use in cervical cancer screening?

Marc Arbyn, Kate Cuschieri, Mario Poljak, Jesper Bonde

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Article Public, Environmental & Occupational Health

VALCOR: a protocol for the validation of SARS-corona virus-2 assays

Marc Arbyn, Sharonjit Kaur Dhillon, Marianna Martinelli, Cindy Simoens, Lize Cuypers, Jannes Bode, Marc Van Ranst, Philippe Corbisier, Jesper Bonde, Clementina Cocuzza

Summary: VALCOR is a study protocol aimed at establishing a framework for the validation of SARS-CoV-2 virus assays. Its objectives are to define common criteria for SARS-CoV-2 assays and generate comprehensive validation data.

ARCHIVES OF PUBLIC HEALTH (2022)

Article Ophthalmology

Inverted papilloma of the conjunctiva

Ingvild Ramberg, Nicolai Christian Sjo, Jesper Hansen Bonde, Steffen Heegaard

BMJ OPEN OPHTHALMOLOGY (2019)

Article Virology

Time and temperature dependent analytical stability of dry-collected Evalyn HPV self-sampling brush for cervical cancer screening

Ditte Moller Ejegod, Helle Pedersen, Garazi Pena Alzua, Camilla Pedersen, Jesper Bonde

PAPILLOMAVIRUS RESEARCH (2018)

Article Oncology

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders

J. U. H. Lam, K. M. Elfstrom, D. M. Ejegod, H. Pedersen, C. Rygaard, M. Rebolj, E. Lynge, K. E. Juul, S. K. Kjaer, J. Dillner, J. Bonde

BRITISH JOURNAL OF CANCER (2018)

暂无数据